Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal estradiol 10 micrograms for vaginal microbiome changes in women with genitourinary syndrome of menopause
TCTR20240514001Phase 3Completed
- Sponsor
- Ratchadaphiseksomphot Endowment Fund
- Start
- Aug 2023
- Countries
- 1
01
Overview
Phase 3, randomised trial in vaginal atrophy comparing Vaginal estradiol with Vaginal placebo tablet (2 arms). Primary endpoint: Characteristics of vaginal microbiome. Started Aug 2023; status: completed.
02
Drugs
estradiol
03
Conditions
vaginal atrophy
Beyond the preview
Go deeper on TCTR20240514001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240514001.